drug: dexfenfluramine

• Clinical class: anorexiant, antiobesity
• Action: serotonin reuptake inhibitor, serotonin releaser
• DEA schedule, number: IV, 1670
• Associated with (substance-related): disorders (possibly)
• Also: fen-phen

U.S. Preparations:

• Redux™ (Wyeth-Ayerst) FDA approved: management of obesity 4.29.96 (voluntarily withdrawn by the manufacturer, announced 9.15.97)

Preparations Outside U.S.:

• Adifax, Adipamin, Dipondal, Glypolix, Isolipan, Isomeride

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2010 BehaveNet®